IE56510B1 - Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon - Google Patents

Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon

Info

Publication number
IE56510B1
IE56510B1 IE2545/83A IE254583A IE56510B1 IE 56510 B1 IE56510 B1 IE 56510B1 IE 2545/83 A IE2545/83 A IE 2545/83A IE 254583 A IE254583 A IE 254583A IE 56510 B1 IE56510 B1 IE 56510B1
Authority
IE
Ireland
Prior art keywords
adsorbent
magnesium trisilicate
products containing
medicament drug
drug adsorbed
Prior art date
Application number
IE2545/83A
Other languages
English (en)
Other versions
IE832545L (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IE832545L publication Critical patent/IE832545L/xx
Publication of IE56510B1 publication Critical patent/IE56510B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heat Treatment Of Steel (AREA)
  • Luminescent Compositions (AREA)
  • External Artificial Organs (AREA)
IE2545/83A 1983-07-20 1983-10-28 Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon IE56510B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/516,002 US4581232A (en) 1983-07-20 1983-07-20 Magnesium trisilicate suitable for preparation of medicament adsorbates

Publications (2)

Publication Number Publication Date
IE832545L IE832545L (en) 1985-01-20
IE56510B1 true IE56510B1 (en) 1991-08-28

Family

ID=24053698

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2545/83A IE56510B1 (en) 1983-07-20 1983-10-28 Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon

Country Status (13)

Country Link
US (1) US4581232A (enExample)
EP (1) EP0132472B1 (enExample)
JP (1) JPS60112722A (enExample)
AT (1) ATE44130T1 (enExample)
AU (1) AU563740B2 (enExample)
CA (1) CA1207232A (enExample)
DE (1) DE3380090D1 (enExample)
DK (1) DK159805C (enExample)
ES (1) ES8607723A1 (enExample)
FI (1) FI79785C (enExample)
IE (1) IE56510B1 (enExample)
NZ (1) NZ206101A (enExample)
ZA (1) ZA838080B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US5891801A (en) * 1987-07-17 1999-04-06 Calam And Associates, Inc. Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor
US5468482A (en) * 1987-07-17 1995-11-21 Calam & Associates, Inc. Palatable orally administered liquid medicaments for relief of discomfort and flavoring combinations therefor
JP2535707Y2 (ja) * 1991-04-05 1997-05-14 日本精工株式会社 リニアガイド装置のストッパ装置
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
KR100759635B1 (ko) * 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
DE60320940D1 (de) * 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
JP2007501218A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
SI1566173T1 (sl) * 2004-02-20 2006-12-31 Mattern Udo Farmacevtska zmes za oralno aplikacijo in postopek njene priprave
NZ555909A (en) * 2004-12-13 2009-11-27 Mcneil Ppc Inc Compositions and methods for reducing the degradation of phenylephrine by oxygen
US20090098192A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
AU2008311350B2 (en) 2007-10-11 2014-04-03 Philip Morris Products S.A. Smokeless tobacco product
US9125434B2 (en) * 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
WO2009099830A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips for immediate release of active ingredients
US20090196908A1 (en) * 2008-01-31 2009-08-06 Der-Yang Lee Edible film-strips with modified release active ingredients
CN110330023B (zh) * 2019-07-17 2020-10-13 云鹏医药集团有限公司 一种三硅酸镁的制备及干燥方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR799950A (fr) * 1935-03-27 1936-06-23 Mutosel Procédé de préparation de silicates complexes de bases organiques
US2881113A (en) * 1957-01-29 1959-04-07 Ortho Pharma Corp Therapeutically active compositions containing amphetamines
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US3449266A (en) * 1964-05-25 1969-06-10 Drackett Co Stabilized solid granular perfume composition
US3272594A (en) * 1965-10-22 1966-09-13 Merck & Co Inc Preparation of magnesium trisilicate
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
GB1236880A (en) * 1969-12-20 1971-06-23 Exp Drugs Company Antacid compositions
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
DE2631947B2 (de) * 1976-07-15 1980-11-27 Bayer Ag, 5090 Leverkusen Verwendung von ätherischen ölen und Äthylalkohol
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
IL58462A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a penicillin
JPS5594315A (en) * 1979-01-11 1980-07-17 Taiyo Yakuhin Kogyo Kk Antibacterial drug
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation

Also Published As

Publication number Publication date
FI79785C (fi) 1990-03-12
EP0132472B1 (en) 1989-06-21
ZA838080B (en) 1984-06-27
DK159805C (da) 1991-05-06
FI840615L (fi) 1985-01-21
FI79785B (fi) 1989-11-30
DE3380090D1 (en) 1989-07-27
NZ206101A (en) 1985-09-13
DK553283D0 (da) 1983-12-01
JPS60112722A (ja) 1985-06-19
IE832545L (en) 1985-01-20
ES526990A0 (es) 1986-06-01
ATE44130T1 (de) 1989-07-15
DK553283A (da) 1985-01-21
US4581232A (en) 1986-04-08
AU563740B2 (en) 1987-07-23
JPH0465811B2 (enExample) 1992-10-21
ES8607723A1 (es) 1986-06-01
AU2068983A (en) 1985-01-24
EP0132472A1 (en) 1985-02-13
CA1207232A (en) 1986-07-08
FI840615A0 (fi) 1984-02-15
DK159805B (da) 1990-12-10

Similar Documents

Publication Publication Date Title
IE832545L (en) Medicated products
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
AU1779488A (en) Polysaccharides and antiviral drugs containing the same as active ingredient
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU6065586A (en) Devices for administering medicaments to patients
AU2152688A (en) Dosage form comprising fast agent delivery followed by slow agent delivery
HK60189A (en) Medicaments for paf acether induced maladies
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
AU1819288A (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
PT82129A (en) Process for the preparation of macroemulsions containing at least one solid pyrethroid as active ingredient
EP0329251A3 (en) Process for the preparation of activated carbon
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
AU6581186A (en) Pharmaceutically active hererocyclic compounds
AU1030388A (en) Improvements relating to filters
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
DE3163391D1 (en) A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient
ZA843846B (en) Histargin,a microbiological process for its preparation,its use as a medicament,and the strain streptomyces roseoviridis having the ability to produce histargin
AU2273088A (en) Pharmaceutical products containing a 7-diphenylmethylene- bicycloheptane or 7-diphenylmethylenebicycloheptene derivative, the use of these compounds as medicaments, and new 7-diphenylmethylenebicycloheptanes and 7-diphenylmethylene-bicycloheptenes and processes for the preparation thereof
GB2221434B (en) Improvements relating to drive axle assemblies
AU1447388A (en) Cholesteryl-phosphoryl choline as pharmaceutically active substances
AU2584788A (en) Medicament with antiemetic action
IE870787L (en) Medicament adsorbate